About this Research Topic
Cancer continues to be one of the most challenging diseases due to the complex molecular mechanisms involved. Epigenetic modifications, particularly histone modifications, play a crucial role in cancer initiation and progression. These modifications, which include methylation, acetylation, phosphorylation, and ubiquitination, can regulate gene expression without changing the underlying DNA sequence, thus influencing cellular processes essential for cancer development. Abnormal histone modifications have been linked to various cancers, impacting tumor suppressor genes and oncogenes, and contributing to cancer cell proliferation, survival, and metastasis. A deeper understanding of these modifications could lead to new therapeutic strategies and drug discoveries.
This Research Topic aims to enhance our knowledge of histone modifications in cancer and their implications for pharmacology and drug discovery. Key research questions include:
• What specific histone modification patterns are associated with different cancer types? Investigating unique histone modification signatures in various cancers can help identify biomarkers for early diagnosis and prognosis.
• Can these patterns predict patient responses to existing cancer therapies? Determining predictive markers could personalize treatment plans and improve outcomes.
• How do histone modifications interact with other epigenetic mechanisms in cancer? Understanding the interplay between histone modifications, DNA methylation, and non-coding RNAs could provide a more comprehensive view of epigenetic regulation in cancer.
• What role do histone modification enzymes play in cancer progression and therapy resistance? Studying enzymes such as histone acetyltransferases (HATs), histone deacetylases (HDACs), and histone methyltransferases (HMTs) can identify potential therapeutic targets to overcome drug resistance.
• What are the potential therapeutic benefits of targeting histone modifications with small molecules or biologics? Exploring the efficacy and safety of HDAC inhibitors, HMT inhibitors, and other epigenetic drugs, as well as alternative medicinal agents, could lead to new cancer treatments.
By exploring the intricate roles of histone modifications in cancer, we anticipate gaining a deeper understanding of their impact on disease progression and therapy response. This research could uncover novel biomarkers for early diagnosis and more personalized treatment plans. Additionally, targeting histone modifications with innovative therapies offers promising avenues for overcoming drug resistance and improving patient outcomes. Ultimately, this work aims to pave the way for breakthroughs in cancer treatment and management.
This Research Topic aims to enhance our knowledge of histone modifications in cancer and their implications for pharmacology and drug discovery. Key research questions include:
• What specific histone modification patterns are associated with different cancer types? Investigating unique histone modification signatures in various cancers can help identify biomarkers for early diagnosis and prognosis.
• Can these patterns predict patient responses to existing cancer therapies? Determining predictive markers could personalize treatment plans and improve outcomes.
• How do histone modifications interact with other epigenetic mechanisms in cancer? Understanding the interplay between histone modifications, DNA methylation, and non-coding RNAs could provide a more comprehensive view of epigenetic regulation in cancer.
• What role do histone modification enzymes play in cancer progression and therapy resistance? Studying enzymes such as histone acetyltransferases (HATs), histone deacetylases (HDACs), and histone methyltransferases (HMTs) can identify potential therapeutic targets to overcome drug resistance.
• What are the potential therapeutic benefits of targeting histone modifications with small molecules or biologics? Exploring the efficacy and safety of HDAC inhibitors, HMT inhibitors, and other epigenetic drugs, as well as alternative medicinal agents, could lead to new cancer treatments.
By exploring the intricate roles of histone modifications in cancer, we anticipate gaining a deeper understanding of their impact on disease progression and therapy response. This research could uncover novel biomarkers for early diagnosis and more personalized treatment plans. Additionally, targeting histone modifications with innovative therapies offers promising avenues for overcoming drug resistance and improving patient outcomes. Ultimately, this work aims to pave the way for breakthroughs in cancer treatment and management.
Keywords: Epigenetics, Histone Modifications, Cancer Progression, Therapeutic Targets, Drug Resistance
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
